Arizona State Retirement System’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$589K Sell
65,372
-1,036
-2% -$16.3K ﹤0.01% 1379
2025
Q4
$1.21M Sell
66,408
-4,215
-6% -$71K 0.01% 1003
2025
Q3
$1.04M Buy
70,623
+1,307
+2% +$22.4K 0.01% 1121
2025
Q2
$1.26M Buy
69,316
+1,531
+2% +$31.2K 0.01% 986
2025
Q1
$1.34M Buy
67,785
+204
+0.3% +$3.53K 0.01% 917
2024
Q4
$1.16M Buy
67,581
+4,170
+7% +$78.5K 0.01% 1026
2024
Q3
$1.27M Buy
63,411
+1,770
+3% +$27.5K 0.01% 986
2024
Q2
$689K Buy
61,641
+2,645
+4% +$22.2K ﹤0.01% 1254
2024
Q1
$389K Sell
58,996
-732
-1% -$4K ﹤0.01% 1577
2023
Q4
$270K Buy
59,728
+2,769
+5% +$10.2K ﹤0.01% 1788
2023
Q3
$204K Buy
56,959
+776
+1% +$2.99K ﹤0.01% 1893
2023
Q2
$207K Sell
56,183
-603
-1% -$2.23K ﹤0.01% 1938
2023
Q1
$188K Buy
56,786
+9,690
+21% +$33.5K ﹤0.01% 1956
2022
Q4
$183K Buy
+47,096
New +$145K ﹤0.01% 1950

Other funds holding ADMA

Arizona State Retirement System's ADMA Position: Q1 2026 in Review

Arizona State Retirement System reduced its ADMA Biologics (ADMA) stake by 1.6% in Q1 2026, selling an estimated $16.3K and leaving 65,372 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

Arizona State Retirement System first reported a position in ADMA in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.34M in Q1 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Arizona State Retirement System held 65,372 shares of ADMA Biologics worth $589K as of Q1 2026.
  • Arizona State Retirement System sold 1,036 ADMA Biologics shares in Q1 2026, an estimated $16.3K.
  • ADMA Biologics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1379 holding.
  • Arizona State Retirement System first reported a position in ADMA Biologics in Q4 2022 and has held it in 14 quarters since.
  • Arizona State Retirement System's ADMA Biologics position peaked at $1.34M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.